Dominant Mutations in Three Different Subunits of Replication Factor C Suppress Replication Defects in Yeast PCNA Mutants

Total Page:16

File Type:pdf, Size:1020Kb

Dominant Mutations in Three Different Subunits of Replication Factor C Suppress Replication Defects in Yeast PCNA Mutants Copyright 1999 by the Genetics Society of America Dominant Mutations in Three Different Subunits of Replication Factor C Suppress Replication Defects in Yeast PCNA Mutants Neelam S. Amin, K. Michelle Tuffo and Connie Holm Department of Pharmacology, Division of Cellular and Molecular Medicine, University of California, San Diego, California 92093-0651 Manuscript received April 23, 1999 Accepted for publication August 25, 1999 ABSTRACT To identify proteins that interact with the yeast proliferating cell nuclear antigen (PCNA), we used a genetic approach to isolate mutations that compensate for the defects in cold-sensitive (Cs2) mutants of yeast PCNA (POL30). Because the cocrystal structure of human PCNA and a p21WAF1/CIP1 peptide shows that the interdomain region of PCNA is a site of p21 interaction, we speci®cally looked for new mutations that suppress mutations in the equivalent region of yeast PCNA. In independent screens using three different Cs2 mutants, we identi®ed spontaneously arising dominant suppressor mutations in the RFC3 gene. In addition, dominant suppressor mutations were identi®ed in the RFC1 and RFC2 genes using a single pol30 mutant. An intimate association between PCNA and RFC1p, RFC2p, and RFC3p is suggested by the allele-restricted suppression of 10 different pol30 alleles by the RFC suppressors. RFC1, RFC2, and RFC3 encode three of the ®ve subunits of the replication factor C complex, which is required to load PCNA onto DNA in reconstituted DNA replication reactions. Genomic sequencing reveals a common region in RFC1p, RFC2p, and RFC3p that is important for the functional interaction with PCNA. Biochemi- cal analysis of the wild type and mutant PCNA and RFC3 proteins shows that mutant RFC3p enhances the production of long DNA products in pol d-dependent DNA synthesis, which is consistent with an increase in processivity. HE proliferating cell nuclear antigen (PCNA) is an fore, the interaction of PCNA and proteins of the RFC Tessential factor in eukaryotic DNA replication and complex may play a crucial role in the execution of repair processes, and it may also be an important target DNA synthesis. PCNA has been shown to function in for coordinating cell-cycle regulation with DNA replica- many DNA repair processes, such as base and nucleotide tion (reviewed in Jonsson and Hubscher 1997 and excision repair (Nichols and Sancar 1992; Shivji et Kelman 1997). During DNA replication, PCNA mark- al. 1992; Matsumoto et al. 1994; Frosina et al. 1996), edly enhances the ef®ciency of incorporation of nucleo- RAD6-dependent error prone repair (Torres-Ramos et tides into DNA by securely attaching the DNA synthesis al. 1996), DNA methylation (Chuang et al. 1997), and machinery onto the DNA (reviewed in So and Downey DNA mismatch repair (Johnson et al. 1996; Umar et al. 1992; Wyman and Botchan 1995; Jonsson and Hub- 1996). That PCNA might play a role in DNA mismatch scher 1997; Kelman 1997). In vitro DNA replication repair is particularly intriguing because mutations in reactions show that PCNA is ®rst loaded onto the DNA known human mismatch repair genes, such as hMSH2, by a complex of ®ve proteins called replication factor hMLH1, and hPMS2, have been linked to colorectal C (RFC) in an ATP-dependent reaction (Lee et al. 1988; cancers (Liu et al. 1996). Lee and Hurwitz 1990; Tsurimoto and Stillman Apart from its role in DNA replication and DNA 1991a; Yoder and Burgers 1991; Fien and Stillman repair, mammalian PCNA is also the target for the bind- 1992; Podust et al. 1995). Next, PCNA binds to the ing of the cyclin-dependent kinase (CDK) inhibitor DNA polymerase (d or ε), and DNA elongation occurs p21WAF1/CIP1 (Xiong et al. 1992, 1993; Zhang et al. 1993; processively (Lee and Hurwitz 1990; Burgers 1991; Flores-Rozas et al. 1994; Waga et al. 1994), which is Lee et al. 1991b; Tsurimoto and Stillman 1991b; induced under conditions of DNA damage in a p53- Podust et al. 1992). Because RFC is also able to unload dependent manner (El-Deiry et al. 1993). Although a PCNA from the DNA, PCNA may be shuttled onto and p21 homolog has not yet been identi®ed in yeast, the off of Okazaki DNA fragments during lagging-strand striking similarities in the crystal structures of human DNA synthesis (Yao et al. 1996; Cai et al. 1997). There- and yeast PCNA suggest that there may be similarities in their regulation as well. Biochemical studies show that p21 blocks DNA synthesis by binding to PCNA (Flores-Rozas et al. 1994; Waga et al. 1994) and that Corresponding author: Connie Holm, Department of Pharmacology, the C-terminal 22 amino acids of p21 are suf®cient to Division of Cellular and Molecular Medicine, University of California, 9500 Gilman Dr., San Diego, CA 92093-0651. inhibit PCNA activity (Warbrick et al. 1995). The deter- E-mail: [email protected] mination of the cocrystal structure of human PCNA and Genetics 153: 1617±1628 ( December 1999) 1618 N. S. Amin, K. M. Tuffo and C. Holm the C-terminal p21 peptide has identi®ed the interdo- For ¯ow cytometry experiments, rho0 strains were created by 1 main and interconnector loop regions of the PCNA growing rho strains CH2165 (POL30), CH2161 (pol30-104), and CH2392 (pol30-104 RFC3-3) in YEPD (see below) con- monomer as the site of interaction of the p21 peptide taining 25 mg/ml ethidium bromide as outlined in Sherman (Gulbis et al. 1996). However, this structure leaves open et al. (1986). A list of all strains used in this study is presented the question of the mechanism of inhibition of DNA in Table 1. synthesis. While it is possible that p21 binding affects YEPD (rich) and SD (synthetic dextrose) media were used the monomer-trimer ratio of PCNA in the cell, it appears to grow yeast cells. YEPD medium contains 1% yeast extract, 2% bactopeptone, 2% dextrose, with the presence or absence more likely that p21 interferes with the binding of essen- of 2% bactoagar. SD medium contains 0.67% yeast nitrogen tial DNA replication proteins to PCNA. Candidates for base, 2% dextrose, and 2% bactoagar. SC (synthetic complete) these essential proteins include DNA polymerases d or medium contains 60 mg of leucine, 30 mg of lysine, and 20 ε, or subunits of RFC. mg of uracil, adenine, histidine, and tryptophan in 1 liter of We have previously used the Saccharomyces cerevisiae SD medium. For MMS-containing plates, MMS (Sigma, St. 2 Louis) was added to autoclaved YEPD at a ®nal concentration PCNA gene to identify cold-sensitive (Cs ) mutations of 0.01, 0.015, or 0.02% prior to pouring plates. Sporulation that affect the interdomain region of the yeast PCNA medium contains 1% potassium acetate, 0.1% yeast extract, protein structure (Amin and Holm 1996). In vivo analy- 2% bactoagar, and 0.05% dextrose. sis of the Cs2 pol30 mutants suggests that the interdo- Pseudoreversion screen: To obtain pseudorevertants of main region of the PCNA monomer is important for pol30 mutants, we selected spontaneously arising suppressors of three different cold-sensitive PCNA mutations. Speci®cally, both ef®cient DNA replication and for repair of methyl 10±33 independent cultures of strain CH2159 (pol30-100), methanesulfonate (MMS) and UV-induced DNA dam- CH2161 (pol30-104), or CH2171 (pol30-108) were grown over- age (Amin and Holm 1996). A comparison of the yeast night in YEPD at 308. Approximately 107 cells derived from and human PCNA structures reveals that they are virtu- each of the pol30 mutant cultures were spread on each YEPD ally superimposable (Krishna et al. 1994; Gulbis et al. plate and incubated at the restrictive temperature of 148 or the semipermissive temperature of 208. The use of two different 1996). Thus, it is striking that the p21 peptide makes temperatures was initially intended to enhance the speci®city contacts with the interconnector loop and the interdo- of the screening process. Spontaneously arising revertant colo- main region of human PCNA, the same region in yeast nies were selected and retested for loss of their Cs2 and Mmss PCNA where our Cs2 mutations are located (Krishna phenotypes. In addition, the revertants were also examined et al. 1994; Gulbis et al. 1996). Furthermore, because for the appearance of new phenotypes, including heat sensitiv- ity or sensitivity to hydroxyurea. cold sensitivity often affects protein-protein interactions Genetic analysis of intragenic and extragenic suppressors: (Cantor and Schimmel 1980; Strauss and Guthrie To determine if suppression of pol30 mutant phenotypes is 1991; McAlear et al. 1994), it is likely that the interdo- conferred by a single gene, the suppressed pol30 strains were main region of PCNA is a key region for protein-protein crossed to a Cs2 strain (CH2159, CH2161, or CH2171) bearing interactions. the same pol30 allele as present in the pseudorevertant. Exami- To identify proteins that interact with the interdomain nation of the phenotype of the diploid strain revealed whether suppression is dominant or recessive. Because the diploid region of yeast PCNA in vivo, we looked for suppression strains were homozygous for the pol30 mutant allele, 2:2 segre- 2 of the defects of three Cs pol30 mutants by spontane- gation of the Cs1 phenotype was indicative of a single gene ously arising mutations in other genes. We obtained conferring suppression upon tetrad analysis. Further analysis both intragenic and extragenic suppressors that are of 24 strains carrying single-gene suppressors was carried out dominant for suppression. In independent screens with to determine whether suppression was due to intragenic or extragenic mutations. The revertant strains were crossed with three different pol30 alleles we obtained extragenic sup- a POL30 strain (CH2237), and tetrad analysis revealed that pressors that affect the RFC3 protein. Additionally, we 12 of the 24 revertants were likely to contain intragenic muta- obtained mutations in RFC1 and RFC2 that suppress the tions; genomic sequencing was used to con®rm that the muta- defects of one of the pol30 alleles.
Recommended publications
  • Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
    Leukemia (2010) 24, 756–764 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 $32.00 www.nature.com/leu ORIGINAL ARTICLE Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells A Pellagatti1, M Cazzola2, A Giagounidis3, J Perry1, L Malcovati2, MG Della Porta2,MJa¨dersten4, S Killick5, A Verma6, CJ Norbury7, E Hellstro¨m-Lindberg4, JS Wainscoat1 and J Boultwood1 1LRF Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK; 2Department of Hematology Oncology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 3Medizinische Klinik II, St Johannes Hospital, Duisburg, Germany; 4Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 5Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK; 6Albert Einstein College of Medicine, Bronx, NY, USA and 7Sir William Dunn School of Pathology, University of Oxford, Oxford, UK To gain insight into the molecular pathogenesis of the the World Health Organization.6,7 Patients with refractory myelodysplastic syndromes (MDS), we performed global gene anemia (RA) with or without ringed sideroblasts, according to expression profiling and pathway analysis on the hemato- poietic stem cells (HSC) of 183 MDS patients as compared with the the French–American–British classification, were subdivided HSC of 17 healthy controls. The most significantly deregulated based on the presence or absence of multilineage dysplasia. In pathways in MDS include interferon signaling, thrombopoietin addition, patients with RA with excess blasts (RAEB) were signaling and the Wnt pathways. Among the most signifi- subdivided into two categories, RAEB1 and RAEB2, based on the cantly deregulated gene pathways in early MDS are immuno- percentage of bone marrow blasts.
    [Show full text]
  • RFC2 Antibody
    Product Datasheet RFC2 Antibody Catalog No: #43122 Orders: [email protected] Description Support: [email protected] Product Name RFC2 Antibody Host Species Rabbit Clonality Polyclonal Purification Antigen affinity purification. Applications WB Species Reactivity Hu Specificity The antibody detects endogenous levels of total RFC2 protein. Immunogen Type peptide Immunogen Description Synthetic peptide of human RFC2 Target Name RFC2 Other Names RFC40 Accession No. Swiss-Prot#: P35250Gene ID: 5982 Calculated MW 39kd Concentration 3.5mg/ml Formulation Rabbit IgG in pH7.4 PBS, 0.05% NaN3, 40% Glycerol. Storage Store at -20°C Application Details Western blotting: 1:200-1:1000 Immunohistochemistry: 1:30-1:150 Images Gel: 10%SDS-PAGE Lysate: 40 µg Lane: Human liver cancer tissue Primary antibody: 1/500 dilution Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution Exposure time: 20 seconds Background This gene encodes a member of the activator 1 small subunits family. The elongation of primed DNA templates by DNA polymerase delta and epsilon requires the action of the accessory proteins, proliferating cell nuclear antigen (PCNA) and replication factor C (RFC). Replication factor C, also called activator 1, is a protein complex consisting of five distinct subunits. This gene encodes the 40 kD subunit, which has been shown to be responsible for binding ATP and may help promote cell survival. Disruption of this gene is associated with Williams syndrome. Alternatively spliced transcript variants Address: 8400 Baltimore Ave., Suite 302, College Park, MD 20740, USA http://www.sabbiotech.com 1 encoding distinct isoforms have been described. A pseudogene of this gene has been defined on chromosome 2.
    [Show full text]
  • Anti-RFC3 (GW21946F)
    3050 Spruce Street, Saint Louis, MO 63103 USA Tel: (800) 521-8956 (314) 771-5765 Fax: (800) 325-5052 (314) 771-5757 email: [email protected] Product Information Anti-RFC3 antibody produced in chicken, affinity isolated antibody Catalog Number GW21946F Formerly listed as GenWay Catalog Number 15-288-21946F, Replication factor C subunit 3 Antibody. – Storage Temperature Store at 20 °C The product is a clear, colorless solution in phosphate buffered saline, pH 7.2, containing 0.02% sodium azide. Synonyms: Replication factor C 3 isoform 1, Replication factor C 38 kDa subunit; RFC38; Activator 1 38 kDa subunit; Species Reactivity: Human, rat A1 38 kDa subunit; RF-C 38 kDa subunit Tested Applications: ELISA, WB Product Description Recommended Dilutions: Recommended starting dilution The elongation of primed DNA templates by DNA for Western blot analysis is 1:500, for tissue or cell staining polymerase delta and epsilon requires the action of the 1:200. accessory proteins proliferating cell nuclear antigen (PCNA) and activator 1. Note: Optimal concentrations and conditions for each application should be determined by the user. NCBI Accession number: NP_002906.1 Swiss Prot Accession number: P40938 Precautions and Disclaimer This product is for R&D use only, not for drug, household, or Gene Information: Human .. RFC3 (5983) other uses. Due to the sodium azide content a material Immunogen: Recombinant protein Replication factor C 3 safety data sheet (MSDS) for this product has been sent to isoform 1 the attention of the safety officer of your institution. Please consult the Material Safety Data Sheet for information Immunogen Sequence: GI # 4506489, sequence 1 - 356 regarding hazards and safe handling practices.
    [Show full text]
  • Structure of the Human Clamp Loader Reveals an Autoinhibited Conformation of a Substrate-Bound AAA+ Switch
    Structure of the human clamp loader reveals an autoinhibited conformation of a substrate-bound AAA+ switch Christl Gaubitza,1, Xingchen Liua,b,1, Joseph Magrinoa,b, Nicholas P. Stonea, Jacob Landecka,b, Mark Hedglinc, and Brian A. Kelcha,2 aDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester MA 01605; bGraduate School of Biomedical Sciences, University of Massachusetts Medical School, Worcester MA 01605; and cDepartment of Chemistry, The Pennsylvania State University, University Park, PA 16802 Edited by Michael E. O’Donnell, HHMI and Rockefeller University, New York, NY, and approved July 27, 2020 (received for review April 20, 2020) DNA replication requires the sliding clamp, a ring-shaped protein areflexia syndrome (15), Hutchinson–Gilford progeria syn- complex that encircles DNA, where it acts as an essential cofactor drome (16), and in the replication of some viruses (17–19). It for DNA polymerases and other proteins. The sliding clamp needs is unknown whether loading by RFC contributes to PARD to be opened and installed onto DNA by a clamp loader ATPase of disease. the AAA+ family. The human clamp loader replication factor C Clamp loaders are members of the AAA+ family of ATPases (RFC) and sliding clamp proliferating cell nuclear antigen (PCNA) (ATPases associated with various cellular activities), a large are both essential and play critical roles in several diseases. De- protein family that uses the chemical energy of adenosine 5′- spite decades of study, no structure of human RFC has been re- triphosphate (ATP) to generate mechanical force (20). Most solved. Here, we report the structure of human RFC bound to AAA+ proteins form hexameric motors that use an undulating PCNA by cryogenic electron microscopy to an overall resolution ∼ spiral staircase mechanism to processively translocate a substrate of 3.4 Å.
    [Show full text]
  • Identification and Characterization of a Novel Non-Homologous End Joining Factor MRI
    Washington University in St. Louis Washington University Open Scholarship Arts & Sciences Electronic Theses and Dissertations Arts & Sciences Spring 5-15-2020 Identification and Characterization of a Novel Non-homologous End Joining Factor MRI Putzer Joseph Hung Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds Part of the Allergy and Immunology Commons, Immunology and Infectious Disease Commons, and the Medical Immunology Commons Recommended Citation Hung, Putzer Joseph, "Identification and Characterization of a Novel Non-homologous End Joining Factor MRI" (2020). Arts & Sciences Electronic Theses and Dissertations. 2201. https://openscholarship.wustl.edu/art_sci_etds/2201 This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST. LOUIS Division of Biology and Biomedical Sciences Immunology Dissertation Examination Committee: Barry Sleckman, Chair Gaya Amarasinghe Brian Edelson Takeshi Egawa Nima Mosammaparast Kenneth Murphy Sheila Stewart Identification and Characterization of a Novel Non-homologous End Joining Factor MRI by Putzer Joseph Hung A dissertation presented to The Graduate School of Washington University in partial fulfillment of the requirements
    [Show full text]
  • Anti-RFC3 (Internal Region) Polyclonal Antibody (DPABH-26536) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
    Anti-RFC3 (internal region) polyclonal antibody (DPABH-26536) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Antigen Description The elongation of primed DNA templates by DNA polymerase delta and epsilon requires the action of the accessory proteins proliferating cell nuclear antigen (PCNA) and activator 1. Immunogen Synthetic peptide derived from an internal sequence of Human RFC3. Isotype IgG Source/Host Rabbit Species Reactivity Human Purification Immunogen affinity purified Conjugate Unconjugated Applications WB, IHC-P Format Liquid Size 100 μg Buffer pH: 7.40; Constituents: 49% PBS, 50% Glycerol, 0.88% Sodium chloride. Note: PBS is without Mg2+ and Ca2+ Preservative 0.02% Sodium Azide Storage Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. GENE INFORMATION Gene Name RFC3 replication factor C (activator 1) 3, 38kDa [ Homo sapiens ] Official Symbol RFC3 Synonyms RFC3; replication factor C (activator 1) 3, 38kDa; replication factor C (activator 1) 3 (38kD); replication factor C subunit 3; A1 38 kDa subunit; MGC5276; RFC; 38 kD subunit; RFC38; RFC, 38 kD subunit; RF-C 38 kDa subunit; activator 1 subunit 3; activator 1 38 kDa subunit; replication factor C 38 kDa subunit; 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved Entrez Gene ID 5983 Protein Refseq NP_002906 UniProt ID A0A024RDQ8 Chromosome Location 13q13.2 Pathway Activation of ATR in response to replication stress; BRCA1-associated genome surveillance complex (BASC); Cell Cycle; Cell Cycle Checkpoints; Cell Cycle, Mitotic; Chromosome Maintenance; DNA Repair Function ATP binding; contributes_to ATPase activity; contributes_to DNA binding; DNA clamp loader activity; nucleotide binding; protein binding; 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 2 © Creative Diagnostics All Rights Reserved.
    [Show full text]
  • Supplementary Table S1. Correlation Between the Mutant P53-Interacting Partners and PTTG3P, PTTG1 and PTTG2, Based on Data from Starbase V3.0 Database
    Supplementary Table S1. Correlation between the mutant p53-interacting partners and PTTG3P, PTTG1 and PTTG2, based on data from StarBase v3.0 database. PTTG3P PTTG1 PTTG2 Gene ID Coefficient-R p-value Coefficient-R p-value Coefficient-R p-value NF-YA ENSG00000001167 −0.077 8.59e-2 −0.210 2.09e-6 −0.122 6.23e-3 NF-YB ENSG00000120837 0.176 7.12e-5 0.227 2.82e-7 0.094 3.59e-2 NF-YC ENSG00000066136 0.124 5.45e-3 0.124 5.40e-3 0.051 2.51e-1 Sp1 ENSG00000185591 −0.014 7.50e-1 −0.201 5.82e-6 −0.072 1.07e-1 Ets-1 ENSG00000134954 −0.096 3.14e-2 −0.257 4.83e-9 0.034 4.46e-1 VDR ENSG00000111424 −0.091 4.10e-2 −0.216 1.03e-6 0.014 7.48e-1 SREBP-2 ENSG00000198911 −0.064 1.53e-1 −0.147 9.27e-4 −0.073 1.01e-1 TopBP1 ENSG00000163781 0.067 1.36e-1 0.051 2.57e-1 −0.020 6.57e-1 Pin1 ENSG00000127445 0.250 1.40e-8 0.571 9.56e-45 0.187 2.52e-5 MRE11 ENSG00000020922 0.063 1.56e-1 −0.007 8.81e-1 −0.024 5.93e-1 PML ENSG00000140464 0.072 1.05e-1 0.217 9.36e-7 0.166 1.85e-4 p63 ENSG00000073282 −0.120 7.04e-3 −0.283 1.08e-10 −0.198 7.71e-6 p73 ENSG00000078900 0.104 2.03e-2 0.258 4.67e-9 0.097 3.02e-2 Supplementary Table S2.
    [Show full text]
  • Early Growth Response 1 Regulates Hematopoietic Support and Proliferation in Human Primary Bone Marrow Stromal Cells
    Hematopoiesis SUPPLEMENTARY APPENDIX Early growth response 1 regulates hematopoietic support and proliferation in human primary bone marrow stromal cells Hongzhe Li, 1,2 Hooi-Ching Lim, 1,2 Dimitra Zacharaki, 1,2 Xiaojie Xian, 2,3 Keane J.G. Kenswil, 4 Sandro Bräunig, 1,2 Marc H.G.P. Raaijmakers, 4 Niels-Bjarne Woods, 2,3 Jenny Hansson, 1,2 and Stefan Scheding 1,2,5 1Division of Molecular Hematology, Department of Laboratory Medicine, Lund University, Lund, Sweden; 2Lund Stem Cell Center, Depart - ment of Laboratory Medicine, Lund University, Lund, Sweden; 3Division of Molecular Medicine and Gene Therapy, Department of Labora - tory Medicine, Lund University, Lund, Sweden; 4Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands and 5Department of Hematology, Skåne University Hospital Lund, Skåne, Sweden ©2020 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2019.216648 Received: January 14, 2019. Accepted: July 19, 2019. Pre-published: August 1, 2019. Correspondence: STEFAN SCHEDING - [email protected] Li et al.: Supplemental data 1. Supplemental Materials and Methods BM-MNC isolation Bone marrow mononuclear cells (BM-MNC) from BM aspiration samples were isolated by density gradient centrifugation (LSM 1077 Lymphocyte, PAA, Pasching, Austria) either with or without prior incubation with RosetteSep Human Mesenchymal Stem Cell Enrichment Cocktail (STEMCELL Technologies, Vancouver, Canada) for lineage depletion (CD3, CD14, CD19, CD38, CD66b, glycophorin A). BM-MNCs from fetal long bones and adult hip bones were isolated as reported previously 1 by gently crushing bones (femora, tibiae, fibulae, humeri, radii and ulna) in PBS+0.5% FCS subsequent passing of the cell suspension through a 40-µm filter.
    [Show full text]
  • RFC5 Antibody (F54778)
    RFC5 Antibody (F54778) Catalog No. Formulation Size F54778-0.4ML In 1X PBS, pH 7.4, with 0.09% sodium azide 0.4 ml F54778-0.08ML In 1X PBS, pH 7.4, with 0.09% sodium azide 0.08 ml Bulk quote request Availability 1-3 business days Species Reactivity Human Format Purified Clonality Polyclonal (rabbit origin) Isotype Rabbit Ig Purity Purified UniProt P40937 Applications Flow cytometry : 1:25 (1x10e6 cells) Western blot : 1:500-1:2000 Limitations This RFC5 antibody is available for research use only. Western blot testing of 1) non-transfected and 2) transfected 293 cell lysate with RFC5 antibody. Western blot testing of human HeLa cell lysate with RFC5 antibody. Predicted molecular weight ~38 kDa. Flow cytometry testing of human HeLa cells with RFC5 antibody; Blue=isotype control, Green= RFC5 antibody. Description The elongation of primed DNA templates by DNA polymerase delta and DNA polymerase epsilon requires the accessory proteins proliferating cell nuclear antigen (PCNA) and replication factor C (RFC). RFC, also named activator 1, is a protein complex consisting of five distinct subunits of 140, 40, 38, 37, and 36 kD. RFC5 is the 36 kD subunit. This subunit can interact with the C-terminal region of PCNA. It forms a core complex with the 38 and 40 kDa subunits. The core complex possesses DNA-dependent ATPase activity, which was found to be stimulated by PCNA in an in vitro system. Application Notes The stated application concentrations are suggested starting points. Titration of the RFC5 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
    [Show full text]
  • Genetic Networks Required to Coordinate Chromosome Replication by DNA Polymerases A, D, and E in Saccharomyces Cerevisiae
    INVESTIGATION Genetic Networks Required to Coordinate Chromosome Replication by DNA Polymerases a, d, and e in Saccharomyces cerevisiae Marion Dubarry,* Conor Lawless,* A. Peter Banks,† Simon Cockell,‡ and David Lydall*,1 *Institute for Cell and Molecular Biosciences, Faculty of Medical Sciences, †High Throughput Screening Facility, Newcastle Biomedicine, and ‡Bioinformatics Support Unit, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom ORCID IDs: 0000-0002-4186-8506 (C.L.); 0000-0003-2478-085X (D.L.) ABSTRACT Three major DNA polymerases replicate the linear eukaryotic chromosomes. DNA polymerase KEYWORDS a-primase (Pol a) and DNA polymerase d (Pol d) replicate the lagging-strand and Pol a and DNA polymerase e DNA replication (Pol e) the leading-strand. To identify factors affecting coordination of DNA replication, we have performed DNA polymerase genome-wide quantitative fitness analyses of budding yeast cells containing defective polymerases. We Profilyzer combined temperature-sensitive mutations affecting the three replicative polymerases, Pol a,Pold,and DIXY Pol e with genome-wide collections of null and reduced function mutations. We identify large numbers of quantitative genetic interactions that inform about the roles that specific genes play to help Pol a,Pold, and Pol e function. fitness analyses Surprisingly, the overlap between the genetic networks affecting the three DNA polymerases does not (QFA) represent the majority of the genetic interactions identified. Instead our data support a model for division of Saccharomyces labor between the different DNA polymerases during DNA replication. For example, our genetic interaction cerevisiae data are consistent with biochemical data showing that Pol e is more important to the Pre-Loading complex than either Pol a or Pol d.
    [Show full text]
  • RFC5 Antibody Cat
    RFC5 Antibody Cat. No.: 23-370 RFC5 Antibody Immunohistochemistry of paraffin-embedded human lung cancer using RFC5 antibody (23-370) at dilution of 1:100 (40x lens). Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human, Mouse, Rat Recombinant fusion protein containing a sequence corresponding to amino acids 181-340 IMMUNOGEN: of human RFC5 (NP_031396.1). TESTED APPLICATIONS: IHC, WB WB: ,1:500 - 1:2000 APPLICATIONS: IHC: ,1:50 - 1:200 POSITIVE CONTROL: 1) HeLa 2) U-251MG September 26, 2021 1 https://www.prosci-inc.com/rfc5-antibody-23-370.html 3) SKOV3 4) MCF-7 5) Mouse liver 6) Mouse spleen PREDICTED MOLECULAR Observed: 38kDa WEIGHT: Properties PURIFICATION: Affinity purification CLONALITY: Polyclonal ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: PBS with 0.02% sodium azide, 50% glycerol, pH7.3. STORAGE CONDITIONS: Store at -20˚C. Avoid freeze / thaw cycles. Additional Info OFFICIAL SYMBOL: RFC5 ALTERNATE NAMES: RFC5, MGC1155, RFC36 GENE ID: 5985 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References The elongation of primed DNA templates by DNA polymerase delta and DNA polymerase epsilon requires the accessory proteins proliferating cell nuclear antigen (PCNA) and replication factor C (RFC). RFC, also named activator 1, is a protein complex consisting of five distinct subunits of 140, 40, 38, 37, and 36 kD. This gene encodes the 36 kD subunit. BACKGROUND: This subunit can interact with the C-terminal region of PCNA. It forms a core complex with the 38 and 40 kDa subunits. The core complex possesses DNA-dependent ATPase activity, which was found to be stimulated by PCNA in an in vitro system.
    [Show full text]
  • The Synthetic Genetic Interaction Spectrum of Essential Genes
    LETTERS The synthetic genetic interaction spectrum of essential genes Armaity P Davierwala1, Jennifer Haynes2, Zhijian Li1,2, Rene´e L Brost1, Mark D Robinson1, Lisa Yu3, Sanie Mnaimneh1, Huiming Ding1, Hongwei Zhu1, Yiqun Chen1, Xin Cheng1, Grant W Brown3, Charles Boone1,2,4, Brenda J Andrews1,2,4 & Timothy R Hughes1,2,4 The nature of synthetic genetic interactions involving essential mapping these genetic interactions2,3. Essential gene function is also genes (those required for viability) has not been previously buffered by both nonessential and other essential genes because hypomorphic (partially functional) alleles of essential genes often http://www.nature.com/naturegenetics examined in a broad and unbiased manner. We crossed yeast strains carrying promoter-replacement alleles for more than have synthetic lethal interactions with deletion alleles of nonessential half of all essential yeast genes1 to a panel of 30 different genes and hypomorphic alleles of other essential genes2,3,7.Genetic mutants with defects in diverse cellular processes. The resulting interactions among essential genes have not been examined system- genetic network is biased toward interactions between atically and objectively because of the inherent difficulty in creating functionally related genes, enabling identification of a and working with hypomorphic alleles. previously uncharacterized essential gene (PGA1) required for specific functions of the endoplasmic reticulum. But there are also many interactions between genes with dissimilar functions, Query gene (crossed to array) Gene Ontology labels (array strains) suggesting that individual essential genes are required for buffering many cellular processes. The most notable feature of the essential synthetic genetic network is that it has an interaction density five times that of nonessential synthetic 2005 Nature Publishing Group Group 2005 Nature Publishing genetic networks2,3, indicating that most yeast genetic © -linked glycosylation -linked interactions involve at least one essential gene.
    [Show full text]